The Pentagon funded a tungsten mine restart, and the company that gets most of the money barely moved

On September 14, 2026 the US Department of War announced a $450 million redeemable preferred equity investment in The Elmet Group, made through the Industrial Base Analysis and Sustainment programme by the Office of the Assistant Secretary of War for Industrial Base Policy. The government takes preferred equity, warrants over up to 19.9% of Elmet’s common stock on a post-transaction basis, and board representation rights, with $200 million drawn at closing. The stated purpose is to establish the only independent ammonium paratungstate facility in North America and to secure long-term access to raw material.

Three days earlier, on September 11, 2026, Elmet signed a binding letter agreement with two listed miners — Blue Moon Metals and EQ Resources — to put US$150-175 million into the Springer Tungsten Complex at Imlay, Nevada. The structure has three parts: a $50 million tungsten prepayment facility from Elmet to Blue Moon, repaid through sales credits against concentrate from Springer; a $25 million equity subscription into Blue Moon; and a $75 million injection into a joint venture that will own and operate the ammonium paratungstate plant, held 70% by Elmet, 20% by Blue Moon and 10% by EQ Resources. Blue Moon retains the mine and the mill outright. Elmet also grants Blue Moon warrants over Elmet shares with an aggregate exercise price of US$25 million, running three years and not exercisable for the first six months. An initial $50 million tranche — half the equity subscription, half the first draw on the prepayment facility — is expected to close within 45 days of September 11, 2026.

Springer has open-pit and underground mines, a mill rated at 1,200 tonnes a day, and an ammonium paratungstate plant capable of up to 4,000 tonnes a year. Mine and mill restart is targeted for the fourth quarter of 2027 and conversion-plant operation for the second half of 2028. Ore from EQ Resources’ Queensland operations is to be shipped to Nevada for processing in the interim. The United States has not mined tungsten commercially since 2015. China accounts for roughly 85% of global tungsten supply and added tungsten products to its export control list in February 2025; ammonium paratungstate has risen more than 550% since.

Share prices verified at the September 16, 2026 close. The Elmet Group $19.84, 10.2% below its one-year high. Blue Moon Metals C$7.43, 35.9% below its one-year high of C$11.59 — and below the C$7.59 at which it closed on September 11, 2026, the day the agreement was signed. EQ Resources A$0.465, sitting exactly at its one-year high, up from A$0.385 on September 11, a 20.8% gain over three sessions on roughly 159 million and 93 million shares traded on September 15 and 16 against volumes nearer 30 million earlier in the month.

Opportunity

The obvious reading of a government industrial-base investment is that the recipient is the trade, and the market has followed that reading: Elmet took the headline, and the only miner that visibly repriced is the one whose name appeared in the Australian press, EQ Resources, which supplies Queensland ore and holds 10% of the conversion joint venture.

Look at where the economics actually land and the allocation looks strange. Blue Moon Metals takes the $25 million equity subscription, the $50 million prepayment facility, 20% of the plant, warrants over $25 million of Elmet stock, and — the part nobody is counting — full ownership of the mine and the mill. Every tonne of domestically mined feedstock the programme is designed to produce comes out of an asset Blue Moon owns. EQ Resources, at 10% of the joint venture and a supplier of interim Australian ore, rose 21% in three sessions. Blue Moon closed below where it stood the day the binding agreement was signed.

There are reasons that need ruling out before this counts as a dislocation. A $25 million equity subscription is dilutive to a company of Blue Moon’s size, and the shares have already tripled from a C$3.24 one-year low, so “36% below the high” describes an asset that has run hard rather than a depressed one. Springer produces nothing until late 2027 at the earliest, and the $175 million headline is a letter agreement, not closed funding.

Hypothesis: the asymmetry in the reaction reflects where the news was read rather than where the value went — an ASX-listed junior with an Australian retail following priced a Queensland ore contract, while a TSX Venture listing with a thinner shareholder base and a more complicated three-part consideration did not get priced at all. That is an inference about attention and market structure, not an established fact about either company’s valuation, and it is exactly the kind of claim that a look at Blue Moon’s share count before and after the subscription would either support or destroy.

The broader point is a dependency one. The Department of War has been funding conversion and processing capacity — this tungsten plant, a gallium facility at an Australian alumina refinery, copper foil, rare-earth separation. Conversion plants do not create atoms. Every one of them creates a durable, contracted, price-insensitive buyer for ore that somebody has to dig up, and the companies holding the Western deposits that feed them are mostly small, listed and thinly followed.

How it could play out

The initial $50 million tranche closes within 45 days of September 11, 2026, converting a letter agreement into funded construction and removing the financing risk that currently sits over the Springer restart. Blue Moon moves from an exploration-stage balance sheet to one with a government-anchored strategic partner, a prepayment facility that monetises concentrate before it is produced, and a defined 2027 production date. If ammonium paratungstate prices hold anywhere near current levels, a 4,000-tonne-a-year plant with a captive North American customer base and no Chinese export-licence exposure is worth a great deal more than the capital being spent on it. The chain extends outward: Elmet needs feedstock beyond Springer and Queensland, which makes every other Western tungsten deposit a candidate for the same treatment, and the pattern of the Department of War funding a converter and then the converter funding a miner becomes a template worth front-running rather than a one-off.

Questions worth asking

• What happens to Blue Moon’s share count when the $25 million subscription lands, and at what price? If the subscription is struck near the market, the flat share price is a dislocation; if it is heavily discounted, the market is right and there is nothing here. This decides the idea.
• Which other Western tungsten deposits could feed an Elmet conversion plant that will want more than Springer and Queensland can supply, and are any of them listed?
• The Department of War has now funded a tungsten converter, a gallium plant and rare-earth separation. Which upstream miners are the unavoidable feedstock for each of those plants, and have any of them been repriced?
• Is there an overlooked loser? A subsidised North American ammonium paratungstate plant with a government offtake changes the economics for every existing Western tungsten trader and for anyone holding inventory bought at post-export-control prices.
• The government is taking warrants over 19.9% of Elmet and board seats. What does an equity-holding, board-represented sovereign customer do to the margin structure of a company that sells mostly to that same customer?
• Springer’s ammonium paratungstate plant does not run until the second half of 2028. What supplies American munitions and machine-tool manufacturers between now and then, and at what price?

Where to look

• Blue Moon Metals — owns the Springer mine and mill, takes the largest share of the package, and closed September 16, 2026 below where it sat the day the deal was signed
• EQ Resources — 10% of the conversion joint venture and the supplier of interim Queensland ore, already at its one-year high
• The Elmet Group — the recipient of the $450 million, now with the US government as a preferred shareholder, warrant holder and board member
• other listed Western tungsten developers — the same programme logic that funded Springer applies to any non-Chinese deposit that could feed a North American converter
• Alcoa — separately the site of a US-funded gallium facility in Western Australia, the closest comparable case of a government paying to build byproduct conversion capacity at an existing Western plant
• US machine-tool, carbide and munitions manufacturers, who are the ultimate buyers and who have been paying post-export-control tungsten prices since early 2025

Thesis check

The documentary base is unusually strong for something this small: a Department of War press release naming the amount, the instrument and the warrant percentage, a binding letter agreement with the ownership split spelled out party by party, and a verifiable three-session divergence between two of the three listed participants. The real weakness is that Blue Moon Metals is a pre-production company whose only revenue from Springer arrives in late 2027 at the earliest, whose share price has already tripled inside a year, and which is about to issue equity — so “it did not move on the news” may be a perfectly rational response to dilution rather than the oversight it looks like.

Sources

US Department of War, $450 million investment in The Elmet Group, Sep 14 2026 · PR Newswire, Blue Moon, Elmet and EQ Resources announce US$150-175 million Springer investment, Sep 14 2026 · Mining Technology, Springer Tungsten Complex secures $150m-175m funding, Sep 2026 · The Northern Miner, Pentagon backs $150M Blue Moon tungsten restart, Sep 2026 · Mining.com, Tungsten breaks records as China export curbs and military demand boost investment, 2026